MYO-INOSITOL
2 g
- Enhances FSH signaling and ovarian response
- Improves oocyte quality and maturation
- Supports fertilization outcomes
INFERTIPASSIVE®
Advanced fertility support formula for improving conception chances
IVF Preparation & Implantation Support
Before Embryo Transfer, Preparation Matters
THE IVF SUCCESS PATHWAY
Infertipassive® supports multiple IVF-related biological pathways through a comprehensive multi-ingredient formula to help optimize oocyte quality, embryo development, endometrial receptivity and implantation readiness.
The IVF Success Pathway
Four key biological stages supported by Infertipassive®
OOCYTE COMPETENCE
Supports oocyte maturation and follicular quality
EMBRYO DEVELOPMENT
Supports cellular energy production and embryo development potential
ENDOMETRIAL RECEPTIVITY
Supports uterine blood flow and endometrial preparation
IMPLANTATION READINESS
Supports implantation environment and oxidative stress balance
Hero Ingredients
Clinically-studied key actives in Infertipassive®
CoQ10
200 mg
- Boosts mitochondrial ATP production
- Reduces oxidative stress and supports oocyte and embryo quality
L-ARGININE
500 mg
- Increases uterine blood flow
- Enhances endometrial receptivity
- Supports implantation readiness
Key Clinical Evidence Highlights
Peer-reviewed scientific validation supporting Infertipassive® IVF preparation and implantation support.
MYO-INOSITOL
CLINICAL OUTCOMES
- Increased:MII Oocyte Rate
- Increased:Fertilization rate
- Increased:Oocyte & Embryo Quality
- Increased:Clinical Pregnancy Rate
- Reduced:Cycle cancellation rate
Meta-analysis (2025)
Systematic Review & Meta-analysis (2025)
Prospective Randomized Study (2016)
Wdowiak et al., 2025 — Expert Position StatementDOI: 10.3390/jcm14020558
Expert Position Statement (2025)
CoQ10
CLINICAL OUTCOMES
- Increased:Clinical pregnancy rate
- Increased:Number of Oocytes Retrieved & Embryo Quality
- Reduced:Oxidative stress
- Reduced:Cycle cancellation rate
Systematic Review & Meta-analysis (2024)
Meta-analysis (2020)
Randomized Controlled Trial
L-ARGININE
CLINICAL OUTCOMES
- Reduced:Uterine artery resistance
- Increased:Endometrial Thickness
- Increased:Endometrial blood flow
- Increased:Endometrial Perfusion & Preparation
- Increased:Clinical pregnancy rate
Randomized Clinical Trial (2025)
DOI: 10.3306/AJHS.2025.40.02.88
Shokri et al., 2025 — Randomized Controlled Trial
Prospective Pilot Study (2010)
Multi-Pathway Nutritional Support
Targets Key Factors of IVF Success
Supports Reproductive Readiness
Backed by Clinical Evidence
Comprehensive fertility support formula for both women and men.
INFERTIPASSIVE®
Comprehensive fertility support formula for both women and men to support reproductive health and improve fertility outcomes.